Institut de Recherche pour le Developpement

OrganisationROR

People

Sources: openalex.org

Trials

  • NCT03765931

    Phase 4, Completed, 274 people, 5 Dec 2018

  • NCT03343431

    Phase 3, Active, not recruiting, 504 people, 17 Nov 2017

  • NCT02777229

    Collaborator, Phase 3, Completed, 616 people, 19 May 2016

  • NCT01745822

    Phase 3, Completed, 654 people, 10 Dec 2012

  • NCT01511237

    Phase 3, Completed, 379 people, 18 Jan 2012

  • NCT00252304

    Collaborator, Phase 2/3, Completed, 641 people, 11 Nov 2005

Grants and prizes

  • European Research Council

    HORIZON-ERC-POC, LOKI: Loiasis-associated chronic kidney disease – towards clinical recognition and policy action, 101292469, €150k, 2026–2027, 7 May 2026

  • European Commission

    HORIZON-JU-RIA, Toxicity of dolutegravir and evaluation of doravirine for alternative 1st line antiretroviral treatment in people living with HIV, 101190925, €378.2k, 2025–2029, 19 May 2025

  • Human Frontier Science Program

    Defying the reproduction-maintenance trade-off: Role of diet in long-lived termite reproductives, RGP0060/2018, 1.4m, 2018–2023, 1 Jul 2018

Sources: cordis.europa.eu, openalex.org